...
首页> 外文期刊>Journal of medical imaging and radiation oncology >MRI patterns of T1 enhancing radiation necrosis versus tumour recurrence in high-grade gliomas
【24h】

MRI patterns of T1 enhancing radiation necrosis versus tumour recurrence in high-grade gliomas

机译:高度胶质瘤中T1增强放射坏死与肿瘤复发的MRI模式

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Introduction Despite the emergence of new imaging technologies, the differentiation of treatment-related changes from recurrent tumour in patients with high-grade gliomas remains a difficult challenge. We evaluated whether specific MRI (magnetic resonance imaging) T1 post-contrast enhancement patterns can help to distinguish between radiation necrosis and tumour recurrence. Methods This study was approved by local institutional review board. Fifty-one patients with World Health Organization grade III-IV glioma underwent reoperation after prior chemoradiation. The percentage of radiation necrosis versus recurrent tumour in reoperation specimens was estimated by an experienced neuropathologist. Enhancement patterns on T1 post-contrast sequences from the MRIs obtained prior to reoperation were evaluated according to pathology. Results T1 contrast enhancement patterns correlating with recurrent tumour included focal solid nodules and solid uniform enhancement with distinct margins. Eighty-five per cent (17/20) of patients with ≥70% recurrent tumour at reoperation demonstrated one of these patterns on preoperative MRI. Enhancement patterns correlating with radiation necrosis included a hazy mesh-like diffuse enhancement and rim enhancement with feathery indistinct margins. Ninety-four per cent (17/18) of patients with ≥70% radiation necrosis demonstrated one of these two patterns. Thirteen cases had more mixed pathology (>30% of tumourecrosis) and demonstrated patterns associated with recurrence and/or necrosis. Compared to MR spectroscopy performed in 10 patients, enhancement patterns on MRI were just as accurate in predicting pathologic diagnosis. Conclusion Identifying distinct patterns of contrast enhancement on MRI may help to differentiate between radiation necrosis and tumour recurrence in high-grade gliomas.
机译:引言尽管出现了新的成像技术,但在高级别神经胶质瘤患者中将治疗相关变化与复发性肿瘤区分开来仍然是一个艰巨的挑战。我们评估了特定的MRI(磁共振成像)T1造影后增强模式是否可以帮助区分放射坏死和肿瘤复发。方法本研究得到当地机构审查委员会的批准。事先进行化学放疗后,有51名世界卫生组织III-IV级神经胶质瘤患者接受了再次手术。由经验丰富的神经病理学家估算再次手术标本中放射坏死与复发性肿瘤的百分比。根据病理学评估了再手术前从MRI获得的T1造影剂序列的增强模式。结果与复发性肿瘤相关的T1对比增强模式包括局灶性实性结节和具有均匀边缘的实性均匀增强。再次手术时复发肿瘤≥70%的患者中有百分之八十五(17/20)在术前MRI上显示出其中一种模式。与辐射坏死相关的增强模式包括朦胧的网状弥散增强和边缘增强,羽状模糊边缘。辐射坏死≥70%的患者中有百分之九十四(17/18)表现出这两种模式之一。 13例有更多的混合病理(> 30%的肿瘤/坏死),并表现出与复发和/或坏死相关的模式。与在10例患者中进行的MR光谱相比,MRI的增强模式在预测病理诊断方面同样准确。结论鉴别MRI增强造影剂的不同模式可能有助于区分高级别胶质瘤的放射坏死和肿瘤复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号